Assessing the impact of exposome on the course of chronic obstructive pulmonary disease and cystc fibrosis: The REMEDIA European Project Approach.

Chronic ostructive pulmonary disease Cystic fibrosis Exposome

Journal

Environmental epidemiology (Philadelphia, Pa.)
ISSN: 2474-7882
Titre abrégé: Environ Epidemiol
Pays: United States
ID NLM: 101719527

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 07 09 2020
accepted: 28 06 2021
entrez: 20 8 2021
pubmed: 21 8 2021
medline: 21 8 2021
Statut: epublish

Résumé

Because of the direct interaction of lungs with the environment, respiratory diseases are among the leading causes of environment-related deaths in the world. Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are two highly debilitating diseases that are of particular interest in the context of environmental studies; they both are characterized by a similar progressive loss of lung function with small bronchi alterations, and a high phenotypic variability of unknown origin, which prevents a good therapeutic efficacy. In the last years, there has been an evolution in the apprehension of the study of diseases going from a restricted "one exposure, one disease" approach to a broader concept with other associating factors, the exposome. The overall objective of the REMEDIA project is to extend the understanding of the contribution of the exposome to COPD and CF diseases. To achieve our aim, we will (1) exploit data from existing cohorts and population registries to create a unified global database gathering phenotype and exposome information; (2) develop a flexible individual sensor device combining environmental and biomarker toolkits; (3) use a versatile atmospheric simulation chamber to simulate the health effects of complex exposomes; (4) use machine learning supervised analyses and causal inference models to identify relevant risk factors; and (5) develop econometric and cost-effectiveness models to assess the costs, performance, and cost-effectiveness of a selection of prevention strategies. The results will be used to develop guidelines to better predict disease risks and constitute the elements of the REMEDIA toolbox. The multidisciplinary approach carried out by the REMEDIA European project should represent a major breakthrough in reducing the morbidity and mortality associated with COPD and CF diseases.

Identifiants

pubmed: 34414348
doi: 10.1097/EE9.0000000000000165
pmc: PMC8367060
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e165

Subventions

Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The Environmental Epidemiology. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest with regard to the content of this report.

Références

Eur Respir J. 2001 Jun;17(6):1201-7
pubmed: 11491165
Am J Respir Crit Care Med. 2003 May 15;167(10):1380-6
pubmed: 12522029
Int J Epidemiol. 2008 Feb;37(1):36-41
pubmed: 17644530
Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847-50
pubmed: 16103423
F1000Res. 2017 May 19;6:726
pubmed: 28620467
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31000678
J Cyst Fibros. 2011 Jun;10 Suppl 2:S152-71
pubmed: 21658634
Clin Sci (Lond). 2014 Feb;126(3):207-21
pubmed: 23875733
Mediators Inflamm. 2018 Apr 8;2018:1309746
pubmed: 29849481
Expert Rev Respir Med. 2018 Jun;12(6):483-492
pubmed: 29750581
Int J Biochem Cell Biol. 2014 Jul;52:94-102
pubmed: 24631642

Auteurs

Manon Benjdir (M)

University Paris-Est Créteil, INSERM, IMRB, Creteil, France.

Étienne Audureau (É)

University Paris-Est Créteil, INSERM, IMRB, Creteil, France.
Public Health Department, Clinical Research Unit (URC), Hôpital Henri-Mondor, Assistance Publique Hôpitaux de Paris (APHP), Créteil, France.

Ariel Beresniak (A)

Data Mining International SA, Geneva, Switzerland.

Patrice Coll (P)

Laboratoire Interuniversitaire des Systèmes Atmosphériques, UMR CNRS 7583, Université de Paris et Université Paris-Est Créteil, Institut Pierre Simon Laplace, Créteil, France.

Ralph Epaud (R)

University Paris-Est Créteil, INSERM, IMRB, Creteil, France.
Department of general pediatrics, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Center for Rare Lung Diseases (RESPIRARE), Créteil, France.

Kristina Fiedler (K)

INSERM Transfert, Paris, France.

Bénédicte Jacquemin (B)

Université Rennes 1, INSERM, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Rennes, France.

Laurent Niddam (L)

Wellspring Kft, Budapest, Hungary.

Spyros N Pandis (SN)

Institute of Chemical Engineering Sciences, FORTH, Patras, Greece.
Department of Chemical Engineering, University of Patras, Patras, Greece.

Gerhard Pohlmann (G)

Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.

Torkjel M Sandanger (TM)

Department of Community Medicine, Health Faculty, UiT-the Arctic University of Norway, Tromsø, Norway.

Kai Simmons (K)

Lipotype GmbH, Dresden, Germany.
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Mette Sørensen (M)

Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Natural Science and Environment, Roskilde University, Roskilde, Denmark.

Patrick Wagner (P)

KU Leuven, Laboratory for Soft Matter and Biophysics, Leuven, Belgium.

Sophie Lanone (S)

University Paris-Est Créteil, INSERM, IMRB, Creteil, France.

Classifications MeSH